English | Español
Press release submission | Aug 27, 2021

Laekna Therapeutics Receives IND Approvals in China and US for Phase Ib/III Global Multi-center Clinical Study of Afuresertib in combination with fulvestrant for patients with HR+/HER2- breast cancer
Press release submission | Aug 27, 2021

Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Severe COVID-19 Patients
Press release submission | Aug 26, 2021

Northern California Patients Now Have Access to Noninvasive Varian Edge Cancer Treatment
Bree Gonzales | Aug 25, 2021

Discovery Behavioral Health acquires treatment center for 'increasingly challenging health environment'
Bree Gonzales | Aug 25, 2021

Surge in PTSD risk for Americans: “It is beginning to feel like we are back where we started'
Bree Gonzales | Aug 25, 2021

Mercy Health raises minimum wage to 'ease the financial stress' of its lower-paid employees
Timothy Stuckey | Aug 25, 2021

Kentucky doctor warns of potential superbug 'that's going to be resistant to all antibiotics'
Bree Gonzales | Aug 25, 2021

'Consumers are choosing Bright HealthCare' as Minneapolis health insurer expands across the country

Trending
Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+ Pharmaceuticals
Patient Daily | Oct 23, 2025

Empower seeks dismissal of Eli Lilly suit in Texas federal court
+ Pharmaceuticals
Patient Daily | Oct 29, 2025

Paragon Health Institute senior fellow: 340B program 'needs real reform'